FP7H2020HORIZON
GenomeScan B.V.
- Country
- NLNetherlands
- Defence projects
- 0
- Projects, all programmes
- 13
- As coordinator
- 0
- EU contribution (CORDIS)
- EUR 1,962,096
- Active
- 2011 to 2022
Projects
13 projects, newest first
| Project | Programme | Year | Role | EU contribution |
|---|---|---|---|---|
| ColoMARKIdentification and development of novel colorectal cancer biomarkers via state-of-the-art liquid biopsy approaches | HORIZON | 2022 | Participant | EUR 274,370 |
| TrainCKDisMultidisciplinary Training in Chronic Kidney Disease: from genetic modifiers to drug discovery | H2020 | 2020 | Participant | EUR 265,620 |
| proEVLifeCycleThe life cycle of extracellular vesicles in prostate cancer: from biogenesis and homing, to functional relevance | H2020 | 2019 | Participant | EUR 265,620 |
| ELBAEuropean Liquid Biopsies Academy - Towards widespread clinical application of blood- based diagnostic tools | H2020 | 2018 | Partner | EUR 0 |
| TransPotTranslational Research Network in Prostate Cancer | H2020 | 2017 | Participant | EUR 319,218 |
| RETHRIMRestoring tissue regeneration in patients with visceral Graft versus Host Disease. | H2020 | 2015 | Participant | EUR 370,000 |
| SYSVASCSystems Biology to Identify Molecular Targets for Vascular Disease Treatment | FP7 | 2014 | Participant | EUR 210,960 |
| OPTIBIOCATOptimized esterase biocatalysts for cost-effective industrial production | FP7 | 2013 | Participant | Not stated |
| IMODE-CKDClinical and system –omics for the identification of the MOlecular DEterminants of established Chronic Kidney Disease | FP7 | 2013 | Participant | EUR 157,908 |
| HEALSHealth and Environment-wide Associations based on Large population Surveys | FP7 | 2013 | Participant | Not stated |
| EPISTOPLong-term, prospective study evaluating clinical and molecular biomarkers of epileptogenesis in a genetic model of epilepsy – tuberous sclerosis complex | FP7 | 2013 | Participant | Not stated |
| EARLYNUTRITIONLong-term effects of early nutrition on later health | FP7 | 2012 | Participant | EUR 98,400 |
| INTREALLInternational study for treatment of childhood relapsed ALL 2010 with standard therapy, systematic integration of new agents, and establishment of standardized diagnostic and research | FP7 | 2011 | Participant | Not stated |
The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them (reuse under Commission Decision 2011/833/EU).
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.
Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.